Engineered exosomes for targeted microRNA delivery to reverse liver fibrosis
Top Cited Papers
- 17 June 2025
- journal article
- Published by Elsevier in Biomaterials
- Vol. 324, 123510
Abstract
No abstract availableKeywords
Funding Information
- Jilin University (2024CX199)
- Jilin University (2024CX045)
- Jilin University (2024CX203)
- National Natural Science Foundation of China (21HAA01203)
- National Natural Science Foundation of China (823B2097)
This publication has 43 references indexed in Scilit:
- Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosisJournal of Controlled Release, 2024
- Reprogramming activated hepatic stellate cells by siRNA-loaded nanocarriers reverses liver fibrosis in miceJournal of Controlled Release, 2023
- Delivery of hydroxycamptothecin via sonoporation: An effective therapy for liver fibrosisJournal of Controlled Release, 2023
- Microfluidics for nano-drug delivery systems: From fundamentals to industrializationActa Pharmaceutica Sinica B, 2023
- Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapyActa Biomaterialia, 2022
- Liposome composition in drug delivery design, synthesis, characterization, and clinical applicationAdvanced Drug Delivery Reviews, 2021
- Lipid based nanocarriers for effective drug delivery and treatment of diabetes associated liver fibrosisAdvanced Drug Delivery Reviews, 2021
- Synergistic MicroRNA Therapy in Liver Fibrotic Rat Using MRI‐Visible Nanocarrier Targeting Hepatic Stellate CellsAdvanced Science, 2019
- Adapting liposomes for oral drug deliveryActa Pharmaceutica Sinica B, 2019
- Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor PenetrationAngewandte Chemie International Edition, 2011